113 related articles for article (PubMed ID: 28404964)
21. The Value of Serum miR-139-3p Expression Level in Predicting Postoperative Survival of Colon Cancer Patients.
Fu G; Xu H; Zhou C
Int J Gen Med; 2022; 15():1405-1412. PubMed ID: 35177926
[TBL] [Abstract][Full Text] [Related]
22. Expression and Clinical Values of Serum miR-155 and miR-224 in Chinese Patients with HCV Infection.
Jin X; Zhang Y; Wang H; Zhang Y
Int J Gen Med; 2022; 15():1393-1403. PubMed ID: 35173476
[TBL] [Abstract][Full Text] [Related]
23. Novel Diagnostic Biomarkers in Colorectal Cancer.
Zygulska AL; Pierzchalski P
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055034
[TBL] [Abstract][Full Text] [Related]
24. Circ-PTPDC1 promotes the Progression of Gastric Cancer through Sponging Mir-139-3p by Regulating ELK1 and Functions as a Prognostic Biomarker.
Li Z; Cheng Y; Fu K; Lin Q; Zhao T; Tang W; Xi L; Sheng L; Zhang H; Sun Y
Int J Biol Sci; 2021; 17(15):4285-4304. PubMed ID: 34803498
[TBL] [Abstract][Full Text] [Related]
25. Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance.
Mazouji O; Ouhajjou A; Incitti R; Mansour H
Front Cell Dev Biol; 2021; 9():660924. PubMed ID: 34150757
[TBL] [Abstract][Full Text] [Related]
26. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.
Druce P; Calanzani N; Snudden C; Milley K; Boscott R; Behiyat D; Martinez-Gutierrez J; Saji S; Oberoi J; Funston G; Messenger M; Walter FM; Emery J
Adv Ther; 2021 Jun; 38(6):3032-3065. PubMed ID: 33907946
[TBL] [Abstract][Full Text] [Related]
27. Cardiac, Hepatic and Renal Dysfunction and IL-18 Polymorphism in Breast, Colorectal, and Prostate Cancer Patients.
Qader G; Aali M; Smail SW; Mahmood K; Hasan B; M-Amen K; Rahman DB; Qadir FA; Mohammad DK; Najmuldeen HH; Rahman FM; Ahmad SI; Salih NS; Khdhr ZM; Mohammed BA; Majeed AM; Hasan XM; Khidhir BH; Muhammad ES; Muhamadsalih BA; Hasan SK; Hamad AJ; Esmail ZK; Ismael CM; Husaen SM; Abdulla CA; Hussen BM; Housein Z; Shekha M; Salihi A
Asian Pac J Cancer Prev; 2021 Jan; 22(1):131-137. PubMed ID: 33507690
[TBL] [Abstract][Full Text] [Related]
28. Hsa_circ_0003645 Promotes Breast Cancer Progression by Regulating miR-139-3p/HMGB1 Axis.
Zhang J; Ke S; Zheng W; Zhu Z; Wu Y
Onco Targets Ther; 2020; 13():10361-10372. PubMed ID: 33116616
[TBL] [Abstract][Full Text] [Related]
29. LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion.
Xiao S; Xu N; Ding Q; Huang S; Zha Y; Zhu H
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32808668
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MEG3 rs3087918 was associated with a decreased breast cancer risk in a Chinese population: a case-control study.
Zheng Y; Wang M; Wang S; Xu P; Deng Y; Lin S; Li N; Liu K; Zhu Y; Zhai Z; Wu Y; Dai Z; Zhu G
BMC Cancer; 2020 Jul; 20(1):659. PubMed ID: 32669097
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins?
Loktionov A
World J Gastrointest Oncol; 2020 Feb; 12(2):124-148. PubMed ID: 32104546
[TBL] [Abstract][Full Text] [Related]
32. Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.
Wan TM; Iyer DN; Ng L
Histol Histopathol; 2020 Mar; 35(3):225-237. PubMed ID: 31617575
[TBL] [Abstract][Full Text] [Related]
33. miR‑139‑3p suppresses the invasion and migration properties of breast cancer cells by targeting RAB1A.
Zhang W; Xu J; Wang K; Tang X; He J
Oncol Rep; 2019 Nov; 42(5):1699-1708. PubMed ID: 31485677
[TBL] [Abstract][Full Text] [Related]
34. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer.
Wang JJ; Wang X; Song YX; Zhao JH; Sun JX; Shi JX; Wu ZH; Wang ZN
Dis Markers; 2019; 2019():2587109. PubMed ID: 31275444
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNAs as Promising Biomarkers in Colorectal Cancer.
Rapado-González Ó; Álvarez-Castro A; López-López R; Iglesias-Canle J; Suárez-Cunqueiro MM; Muinelo-Romay L
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252648
[TBL] [Abstract][Full Text] [Related]
36. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.
Chen B; Xia Z; Deng YN; Yang Y; Zhang P; Zhu H; Xu N; Liang S
Open Biol; 2019 Jan; 9(1):180212. PubMed ID: 30958116
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
Prahm KP; Høgdall C; Karlsen MA; Christensen IJ; Novotny GW; Høgdall E
PLoS One; 2018; 13(11):e0207319. PubMed ID: 30475821
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-139-3p regulates osteoblast differentiation and apoptosis by targeting ELK1 and interacting with long noncoding RNA ODSM.
Wang Y; Wang K; Hu Z; Zhou H; Zhang L; Wang H; Li G; Zhang S; Cao X; Shi F
Cell Death Dis; 2018 Oct; 9(11):1107. PubMed ID: 30382082
[TBL] [Abstract][Full Text] [Related]
39. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
Hibner G; Kimsa-Furdzik M; Francuz T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2.
Liu J; Jia Y; Jia L; Li T; Yang L; Zhang G
Oncol Res; 2019 Feb; 27(2):269-279. PubMed ID: 29562959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
